←Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Squamous Cell Carcinoma Asia
Rui-Hua Xu
MD, PhD
🏢Sun Yat-sen University Cancer Center🌐China
President and Professor
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Rui-Hua Xu is a leading Chinese GI oncologist who has led major immunotherapy trials for esophageal squamous cell carcinoma in Chinese patient populations. His research addresses the unique epidemiology and treatment patterns of ESCC in China. He directs one of Asia's largest gastrointestinal oncology clinical trials programs.
Share:
🧪Research Fields 研究领域
Esophageal squamous cell carcinoma
Chinese clinical trials
Immunotherapy combinations
GI oncology
Translational research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Rui-Hua Xu 的研究动态
Follow Rui-Hua Xu's research updates
留下邮箱，当我们发布与 Rui-Hua Xu（Sun Yat-sen University Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment